These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 22496745)

  • 1. Distinct cytoplasmic and nuclear functions of the stress induced protein DDIT3/CHOP/GADD153.
    Jauhiainen A; Thomsen C; Strömbom L; Grundevik P; Andersson C; Danielsson A; Andersson MK; Nerman O; Rörkvist L; Ståhlberg A; Åman P
    PLoS One; 2012; 7(4):e33208. PubMed ID: 22496745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear expression of FLT1 and its ligand PGF in FUS-DDIT3 carrying myxoid liposarcomas suggests the existence of an intracrine signaling loop.
    Andersson MK; Göransson M; Olofsson A; Andersson C; Aman P
    BMC Cancer; 2010 Jun; 10():249. PubMed ID: 20515481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FUS-CHOP fusion protein expression coupled to p53 deficiency induces liposarcoma in mouse but not in human adipose-derived mesenchymal stem/stromal cells.
    Rodriguez R; Rubio R; Gutierrez-Aranda I; Melen GJ; Elosua C; García-Castro J; Menendez P
    Stem Cells; 2011 Feb; 29(2):179-92. PubMed ID: 21732477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-kappaB target genes by interaction with NFKBIZ.
    Göransson M; Andersson MK; Forni C; Ståhlberg A; Andersson C; Olofsson A; Mantovani R; Aman P
    Oncogene; 2009 Jan; 28(2):270-8. PubMed ID: 18850010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myxoid liposarcoma FUS-DDIT3 fusion oncogene induces C/EBP beta-mediated interleukin 6 expression.
    Göransson M; Elias E; Ståhlberg A; Olofsson A; Andersson C; Aman P
    Int J Cancer; 2005 Jul; 115(4):556-60. PubMed ID: 15688424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The myxoid liposarcoma specific TLS-CHOP fusion protein localizes to nuclear structures distinct from PML nuclear bodies.
    Thelin-Järnum S; Göransson M; Burguete AS; Olofsson A; Aman P
    Int J Cancer; 2002 Feb; 97(4):446-50. PubMed ID: 11802205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myxoid liposarcoma-associated EWSR1-DDIT3 selectively represses osteoblastic and chondrocytic transcription in multipotent mesenchymal cells.
    Suzuki K; Matsui Y; Higashimoto M; Kawaguchi Y; Seki S; Motomura H; Hori T; Yahara Y; Kanamori M; Kimura T
    PLoS One; 2012; 7(5):e36682. PubMed ID: 22570737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DDIT3/CHOP and the sarcoma fusion oncoprotein FUS-DDIT3/TLS-CHOP bind cyclin-dependent kinase 2.
    Bento C; Andersson MK; Aman P
    BMC Cell Biol; 2009 Dec; 10():89. PubMed ID: 20017906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of genomic binding sites and direct target genes for the transcription factor DDIT3/CHOP.
    Osman A; Lindén M; Österlund T; Vannas C; Andersson L; Escobar M; Ståhlberg A; Åman P
    Exp Cell Res; 2023 Jan; 422(1):113418. PubMed ID: 36402425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarray analysis reveals ONC201 mediated differential mechanisms of CHOP gene regulation in metastatic and nonmetastatic colorectal cancer cells.
    Al Madhoun A; Haddad D; Al Tarrah M; Jacob S; Al-Ali W; Nizam R; Miranda L; Al-Rashed F; Sindhu S; Ahmad R; Bitar MS; Al-Mulla F
    Sci Rep; 2021 Jun; 11(1):11893. PubMed ID: 34088951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The myxoid/round cell liposarcoma fusion oncogene FUS-DDIT3 and the normal DDIT3 induce a liposarcoma phenotype in transfected human fibrosarcoma cells.
    Engström K; Willén H; Kåbjörn-Gustafsson C; Andersson C; Olsson M; Göransson M; Järnum S; Olofsson A; Warnhammar E; Aman P
    Am J Pathol; 2006 May; 168(5):1642-53. PubMed ID: 16651630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory mechanisms, expression levels and proliferation effects of the FUS-DDIT3 fusion oncogene in liposarcoma.
    Åman P; Dolatabadi S; Svec D; Jonasson E; Safavi S; Andersson D; Grundevik P; Thomsen C; Ståhlberg A
    J Pathol; 2016 Apr; 238(5):689-99. PubMed ID: 26865464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of transmembrane protein 132A by RNA interference facilitates serum starvation-induced cell death in Neuro2a cells.
    Oh-hashi K; Imai K; Koga H; Hirata Y; Kiuchi K
    Mol Cell Biochem; 2010 Sep; 342(1-2):117-23. PubMed ID: 20455009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fat-specific FUS-DDIT3-transgenic mice establish PPARgamma inactivation is required to liposarcoma development.
    Pérez-Mancera PA; Vicente-Dueñas C; González-Herrero I; Sánchez-Martín M; Flores-Corral T; Sánchez-García I
    Carcinogenesis; 2007 Oct; 28(10):2069-73. PubMed ID: 17468515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mechanistic study on the metastasis inducing function of FUS-CHOP fusion protein in liposarcoma.
    Patil N; Ahmed Kabeer Rasheed S; Abba M; Hendrik Leupold J; Schwarzbach M; Allgayer H
    Int J Cancer; 2014 Jun; 134(12):2808-19. PubMed ID: 24285420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GADD153 mediates celecoxib-induced apoptosis in cervical cancer cells.
    Kim SH; Hwang CI; Juhnn YS; Lee JH; Park WY; Song YS
    Carcinogenesis; 2007 Jan; 28(1):223-31. PubMed ID: 17166886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation status of DDIT3 gene in chronic myeloid leukemia.
    Wang YL; Qian J; Lin J; Yao DM; Qian Z; Zhu ZH; Li JY
    J Exp Clin Cancer Res; 2010 May; 29(1):54. PubMed ID: 20492726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene of the month: DDIT3.
    Diaz-Perez JA; Kerr DA
    J Clin Pathol; 2024 Mar; 77(4):211-216. PubMed ID: 38053287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of GADD153 expression in the apoptotic signaling of N-(4-hydroxyphenyl)retinamide (4HPR).
    Xia Y; Wong NS; Fong WF; Tideman H
    Int J Cancer; 2002 Nov; 102(1):7-14. PubMed ID: 12353227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon.
    Italiano A; Bianchini L; Keslair F; Bonnafous S; Cardot-Leccia N; Coindre JM; Dumollard JM; Hofman P; Leroux A; Mainguené C; Peyrottes I; Ranchere-Vince D; Terrier P; Tran A; Gual P; Pedeutour F
    Int J Cancer; 2008 May; 122(10):2233-41. PubMed ID: 18214854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.